In CML, SOCS1 is strongly induced by BCR-ABL, but its role is complex, since it can inhibit both pro-proliferative responses mediated by IL-3 and IL-6, as well as anti-proliferative responses to IFNs. The gene discussed is SOCS1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.